Christian  Vasquez net worth and biography

Christian Vasquez Biography and Net Worth

Insider of BioAtla
Mr. Vasquez has served as our Corporate Controller since November 2015, and as our VP of Finance since July 2020. Mr. Vasquez has over 20 years of Finance and business experience working with both public and private companies. He began his career with KPMG in their San Diego office’s audit practice. Prior to joining BioAtla, he served as an Associate Director of Accounting with Cricket Communications, a publicly-traded company that was acquired by AT&T. Throughout his career, Mr. Vasquez has held various accounting and finance positions of increasing responsibility. Mr. Vasquez received his BS degree in Accountancy from San Diego State University and is a Certified Public Accountant in the state of California.

What is Christian Vasquez's net worth?

The estimated net worth of Christian Vasquez is at least $353,318.96 as of March 28th, 2023. Mr. Vasquez owns 102,709 shares of BioAtla stock worth more than $353,319 as of March 29th. This net worth approximation does not reflect any other investments that Mr. Vasquez may own. Additionally, Mr. Vasquez receives an annual salary of $408,750.00 as Insider at BioAtla. Learn More about Christian Vasquez's net worth.

How old is Christian Vasquez?

Mr. Vasquez is currently 48 years old. There are 3 older executives and no younger executives at BioAtla. The oldest executive at BioAtla is Mr. Richard A. Waldron, Senior VP & CFO, who is 70 years old. Learn More on Christian Vasquez's age.

What is Christian Vasquez's salary?

As the Insider of BioAtla, Inc., Mr. Vasquez earns $408,750.00 per year. There are 3 executives that earn more than Mr. Vasquez. The highest earning executive at BioAtla is Dr. Jay M. Short Ph.D., Co-Founder, CEO & Chairman, who commands a salary of $1,060,000.00 per year. Learn More on Christian Vasquez's salary.

How do I contact Christian Vasquez?

The corporate mailing address for Mr. Vasquez and other BioAtla executives is , , . BioAtla can also be reached via phone at 858-558-0708 and via email at [email protected]. Learn More on Christian Vasquez's contact information.

Has Christian Vasquez been buying or selling shares of BioAtla?

Christian Vasquez has not been actively trading shares of BioAtla during the past quarter. Most recently, on Tuesday, March 28th, Christian Vasquez bought 20,000 shares of BioAtla stock. The stock was acquired at an average cost of $2.40 per share, with a total value of $48,000.00. Following the completion of the transaction, the insider now directly owns 102,709 shares of the company's stock, valued at $246,501.60. Learn More on Christian Vasquez's trading history.

Who are BioAtla's active insiders?

BioAtla's insider roster includes Guy Levy (Director), Jay Short (CEO), Eric Sievers (Insider), Scott Smith (President), Lawrence Steinman (Director), Christian Vasquez (Insider), and Richard Waldron (CFO). Learn More on BioAtla's active insiders.

Are insiders buying or selling shares of BioAtla?

During the last year, BioAtla insiders bought shares 5 times. They purchased a total of 116,800 shares worth more than $263,176.00. The most recent insider tranaction occured on December, 26th when Director Sylvia Mcbrinn bought 4,000 shares worth more than $9,320.00. Insiders at BioAtla own 8.4% of the company. Learn More about insider trades at BioAtla.

Information on this page was last updated on 12/26/2023.

Christian Vasquez Insider Trading History at BioAtla

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/28/2023Buy20,000$2.40$48,000.00102,709View SEC Filing Icon  
6/9/2022Buy10,000$2.97$29,700.0074,525View SEC Filing Icon  
6/7/2022Buy14,152$3.04$43,022.0838,677View SEC Filing Icon  
12/1/2021Sell1,011$23.04$23,293.44View SEC Filing Icon  
11/29/2021Sell642$23.89$15,337.38View SEC Filing Icon  
11/24/2021Sell750$24.87$18,652.50View SEC Filing Icon  
11/22/2021Sell691$26.23$18,124.93View SEC Filing Icon  
See Full Table

Christian Vasquez Buying and Selling Activity at BioAtla

This chart shows Christian Vasquez's buying and selling at BioAtla by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioAtla Company Overview

BioAtla logo
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, melanoma, and head and neck cancer; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California.
Read More

Today's Range

Now: $3.44
Low: $3.33
High: $3.55

50 Day Range

MA: $2.50
Low: $1.88
High: $3.46

2 Week Range

Now: $3.44
Low: $1.24
High: $4.07

Volume

703,194 shs

Average Volume

484,902 shs

Market Capitalization

$164.91 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.02